Tech Transfer Central
Tech Transfer eNews

Tech Transfer E-News provides a weekly round-up of current news and information in the world of tech transfer, delivered every Wednesday (sign up here). It is published by Technology Transfer Tactics newsletter, which is available as a monthly subscription. For more information or to order a subscription click here, or for a sample issue, click here.

Comings and Goings

Duke University’s Office of Licensing and Ventures is being renamed to reflect the university’s efforts to expand its commercialization activities, and the office’s director is getting a new title.

Robin Rasor will now serve as Associate Vice President for Translation and Commercialization. She will lead the re-named Office of Translation & Commercialization, which oversees the protection, marketing and licensing of technologies developed by Duke researchers.

The Office also includes a New Ventures group that specializes in helping faculty and staff who want to form companies around their innovations.

“The university’s pipeline and the deal flow that comes out of it have grown quite nicely over the past few years,” says Rasor, who joined Duke five years ago. “In particular, we have focused on ensuring that our agreement terms are commensurate with our peers and that we close as many deals as possible. The number of our start-ups has increased, and we’re focused on the quality of the start-ups in terms of their attractiveness to investors and potential for exits via public markets or acquisitions.”

Last year alone, Duke launched 17 start-ups and executed 105 technology license agreements, while bringing in $65 million in revenue from its commercialization activities.

“We are definitely making progress as evidenced by the increased numbers of licenses and start-ups,” Rasor says. “But we have a chance to continually do better with the ongoing

restructuring of how we manage translation and commercialization at Duke.”

Source: Duke Today

– – – – – – – – – – – – – – –

New York University (NYU) Langone Health has chosen Marc Sedam, a nationally renowned biotech innovation expert, to serve as vice president for Technology Opportunity Ventures.

In his new role, Sedam will help oversee efforts to promote the commercialization of technologies developed at NYU Langone Health, NYU, and NYU Tandon School of Engineering. He will also help facilitate research collaborations between NYU scientists and industry partners.

Sedam brings over 25 years of experience in technology commercialization. He has served as chief operating officer at a biotech firm and has led tech transfer efforts in academia, most recently at the University of New Hampshire. In all, he has overseen hundreds of IP collaborations and more than 50 start-up launches, including two as a founding member.

“Marc comes to NYU Langone with an extensive background in intellectual asset management, licensing, and start-up formation,” says Daniel J. Widawsky, executive vice president and vice dean at NYU Langone. “We are pleased to have Marc join our team to transform Technology Opportunity Ventures into a center of excellence in entrepreneurship and research investment.”

Source: news wise

Posted under: Tech Transfer e-News